• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2027 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Proffered Presentations

2026 Proffered Presentations

 

← Back to Previous Page

 

S294: INDICATIONS AND LIMITATIONS OF ENDOSCOPIC TRANSNASAL SURGERY FOR POSTERIOR FOSSA INTRADURAL TUMORS: INSIGHTS FROM 53 CASES
Hirotaka Hasegawa, MD, PhD1; Masahiro Shin, MD, PhD2; Shunya Hanakita, MD, PhD1; Hideaki Ono, MD, PhD3; Yuki Shinya, MD, PhD3; Motoyuki Umekawa, MD3; Satoshi Koizumi, MD3; Naoyuki Shono, MD, PhD3; Taichi Kin, MD, PhD3; Nobuhito Saito, MD, PhD3; 1Saitama Medical Center, Saitama Medical University; 2Teikyo University; 3The University of Tokyo

Introduction: Open craniotomy is the benchmark for intradural posterior fossa tumors, yet endoscopic transnasal surgery (ETS) promises comparable oncologic control with less morbidity. Its exact indications and safety remain debated.

Objective: To clarify the role of ETS for these tumors through a single-center series.

Methods: We retrospectively reviewed 53 consecutive patients (June 2016 – April 2025). Twenty-nine had pure intradural lesions (IT) and 24 skull-base tumors with intradural extension (SB-IE). All procedures used a transclival route; pituitary transposition or transodontoid extension was added when required. Resection grade and morbidity were assessed from operative notes and postoperative MRI.

Results: Histology and brain-stem distribution are shown in Figure 1.

Fig 1. Tumor type and location

Gross, near-total, subtotal (>90 %), and partial (<90 %) resections numbered 16, 12, 18, and 7 cases, respectively. Limiting factors were lateral spread to cranial nerves, caudal extension beyond the odontoid, dense neurovascular adhesion, and tumor firmness. All cases experienced intra-operative high-flow cerebrospinal fluid leakage; six early patients required re-operation. After routine suture-based closure began in May 2023, leakage dropped to 0/20 versus 6/33 previously. Transient abducens palsy occurred in eight patients (15 %); mild but permanent ocular palsy in one (2 %); other morbidity was minor. Resection rates and complications did not differ between IT and SB-IE cohorts. Illustrative cases are shown in Figure 2 (foramen magnum meningioma), 3 (cerebellopontine angle epidermoid cyst), and 4 (posterior clinoid meningioma).

Fig 2. Illustrative case (foramen magnum meningioma)

Fig 3. Illustrative case (CP angle epidermoid)

Fig 4. An illustrative case (posterior clinoid meningioma)

Conclusions: ETS affords effective resection with functional preservation when lesions lie medial to cranial nerves and rostral to the odontoid. Lateral reach is reliable inside the cranial-nerve plane, whereas ultimate resectability depends on tumor consistency and adhesiveness. Even in cases beyond these boundaries, ETS may play a valuable role within a multimodal treatment strategy aimed at decompression and functional preservation. ETS therefore represents a valuable standalone or adjunct option within multimodal strategies for posterior fossa disease.

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved